Monday, October 14
2.0 CME/CE CREDITS
Coronary heart disease is the largest killer in the Western world, and biochemical markers, including troponin, BNP, and NTproBNP, are essential for patient care. Cardiac troponin measurement is the cornerstone for diagnosis, risk stratification, and management of suspected myocardial infarction. However, all troponin assays are not created equal; knowledge of test characteristics is vital for appropriate laboratory medicine practice. Establishing the decision point and strategy for determining the rise and/or fall indicating acute myocardial injury is critical for interpretation. Additionally, BNP or NTproBNP are useful for diagnosis and risk assessment of acute decompensated heart failure (HF) and, increasingly, for guiding management. This session will provide participants with the information necessary for optimum laboratory medicine support of acutely presenting coronary heart disease patients.
You will learn to:
Robert H. Christenson, PhD, D(ABCC)
Christopher R. deFilippi, MD